Manal Mohammed Younis
Department of Pharmacovigilance, Iraqi Pharmacovigilance Center, Baghdad, IraqPublications
-
Research Article
Consequences behind Tramadol Dispensing Ban in Iraqi Private Health Sectors
Author(s): Samer Shukur Mohammed41482*, Wael Walid Mustafa41483 and Manal Mohammed Younis41484
Tramadol is codeine analogue with 4-phenyl-piperidine group; it has less analgesic power than morphine but with better abuse potential. However, chronic use associated with different adverse effects like anxiety, euphoria, nervousness, insomnia, depression, agitation. In this study, we assessed the outcome behind restriction of dispensing Tramadol in private health sectors in Iraq. Methods: To assess Tramadol information gathered through searching in VigiBase data and their related Individual Case Safety Report (ICSR) that is officially supported by WHO global database. All reports were analyzed by Vigilyze mining of data and by computing IC25 to evaluate the strength of association between Tramadol and its related disorders, and comparing it with between with worldwide records. Results: 184 cases were collected across 7.. Read More»
DOI: 10.31858/0975-8453.13.7.439-442